101.51
0.00
(0.00%)
At close: January 31 at 3:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-690,824.00
-425,668.00
-942,311.00
-1,211,971.00
-688,716.00
Investing Cash Flow
-7,476,963.00
-1,094,033.00
281,259.00
-18,121.00
-196,807.00
Financing Cash Flow
8,298,694.00
907,014.00
587,500.00
1,332,751.00
760,941.00
End Cash Position
515,348.00
449,311.00
1,069,234.00
1,129,103.00
960,221.00
Capital Expenditure
-20,542.00
-23,749.00
-11,710.00
-22,133.00
-25,044.00
Issuance of Capital Stock
8,538,210.00
1,563,950.00
1,084,661.00
775,045.00
832,866.00
Issuance of Debt
--
--
--
647,906.00
--
Repayment of Debt
--
-525,764.00
-436,088.00
--
--
Repurchase of Capital Stock
-351,834.00
-41,600.00
--
-28,590.00
--
Free Cash Flow
-711,366.00
-449,417.00
-954,021.00
-1,234,104.00
-713,760.00
12/31/2020 - 2/25/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0O2.F Sagimet Biosciences Inc.
3.8600
-1.03%
MRUS Merus N.V.
40.94
-1.52%
BIOSGN.ST Biosergen AB
0.4890
-5.96%
AKESF Akeso, Inc.
7.10
0.00%
RGRX RegeneRx Biopharmaceuticals, Inc.
0.0014
0.00%
ATHA Athira Pharma, Inc.
0.5253
-1.63%
NUVB Nuvation Bio Inc.
2.3100
-3.75%
TLPPF Telix Pharmaceuticals Limited
17.99
0.00%
AVBP ArriVent BioPharma, Inc.
28.54
-1.89%
APGE Apogee Therapeutics, Inc.
41.36
-2.68%